Home » Topics » BioWorld Science

BioWorld Science
RSS

Preclinical data support role of idronoxil as anti-inflammatory for early-stage COVID-19

Aug. 30, 2021

Insilico Medicine to use 4B Technologies' AI technology in drug discovery for neurological diseases

Aug. 30, 2021

Innovent Biologics and Bolt Biotherapeutics collaborate to develop ISAC candidates

Aug. 30, 2021

Homozygous missense variant in PTPN2 gene tied to early-onset Crohn's disease

Aug. 30, 2021

Novel quinuclidine modulator of cellular progranulin shows promising ADME-PK properties

Aug. 30, 2021

Pan-caspase inhibitor shows in vivo efficacy against MRSA and other bacterial skin infections

Aug. 30, 2021

TH-1902, a new docetaxel-peptide conjugate with efficacy in SORT1-positive TNBC models

Aug. 30, 2021

CELMoD CC-99282 for hematological malignancies

Aug. 30, 2021

Study may lead to new pulmonary fibrosis treatments

Aug. 30, 2021

LX-9211: development of an AAK1 inhibitor for neuropathic pain

Aug. 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...